Search
Results 1-7 of 7 (Search time: 0.002 seconds).
Item hits:
Issue Date | Title | Author(s) |
---|
2017-07 | CT-P13 in the treatment of rheumatoid arthritis | 유대현 |
2017-11 | Comparative effectiveness of the biosimilar CT-P13 | 유대현 |
2016-04 | A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study | 유대현 |
2013-10 | Impact Of CT-P13 and Originator Infliximab Treatment On Quality Of Life Derived From The Health Assessment Questionnaire (HAQ) and Short-Form 36 (SF-36) From a Randomized, Double-Blind Trial In Patients With Active RA | 유대현 |
2015-10 | Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product | 유대현 |
2015-10 | Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I study | 유대현 |
2016-01 | Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study | 유대현 |
Discover